Regulations

Private Label Grooming Gets an FDA Warning Letter

Identifies significant violations of Current Good Manufacturing Practice (CGMP) regulations for finished pharmaceuticals.

Author Image

By: TOM BRANNA

Editor

The US Food and Drug Administration issued a Warning Letter to GussyUp LLC dba Private Label Grooming, a Nevada LLC. The Warning Letter summarized “significant violations” of Current Good Manufacturing Practice (CGMP) regulations for finished pharmaceuticals. Private Label Grooming provides progressive barbers and salons the opportunity to offer clients their own exclusive range. According to the FDA, the firm’s quality control unit failed to exercise its responsibility to ensure ...

Continue reading this story and get 24/7 access to Happi for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Happi Newsletters